- Report
- March 2024
- 185 Pages
Global
From €3237EUR$3,374USD£2,781GBP
€3596EUR$3,749USD£3,090GBP
- Report
- May 2024
- 196 Pages
Global
From €4748EUR$4,950USD£4,079GBP
- Report
- April 2022
- 175 Pages
Global
From €3055EUR$3,185USD£2,625GBP
€4365EUR$4,550USD£3,750GBP
- Report
- April 2023
- 110 Pages
Global
From €4557EUR$4,750USD£3,914GBP
- Report
- August 2019
Global
From €4317EUR$4,500USD£3,708GBP
- Report
- March 2020
- 236 Pages
Global
From €3453EUR$3,600USD£2,967GBP
- Report
- March 2020
- 91 Pages
Asia Pacific
From €1439EUR$1,500USD£1,236GBP
- Report
- March 2020
- 90 Pages
Middle East, Africa
From €1439EUR$1,500USD£1,236GBP
- Report
- March 2020
- 90 Pages
Europe
From €1439EUR$1,500USD£1,236GBP
- Report
- March 2020
- 78 Pages
North America
From €1439EUR$1,500USD£1,236GBP
The PEP Device market is a subset of the larger Respiratory Devices market. PEP Devices are Positive Expiratory Pressure devices, which are used to help clear airways of mucus and other secretions. They are used to treat a variety of respiratory conditions, including asthma, bronchitis, and COPD. PEP Devices are typically handheld devices that use a combination of air pressure and vibration to help clear the airways. They are often used in conjunction with other respiratory treatments, such as inhalers and nebulizers.
The PEP Device market is growing due to increasing prevalence of respiratory conditions, as well as technological advancements in the devices. PEP Devices are becoming increasingly user-friendly and portable, making them more accessible to a wider range of patients.
Some companies in the PEP Device market include Philips Respironics, ResMed, Fisher & Paykel, and Vyaire Medical. Show Less Read more
